-
1
-
-
0141468244
-
Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention
-
American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
-
Sarnak MJ, Levey AS, Schoolwerth AC, Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108: 2154-69.
-
(2003)
Circulation
, vol.108
, pp. 2154-2169
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
Sarnak, M.J.4
Levey, A.S.5
Schoolwerth, A.C.6
Coresh, J.7
Culleton, B.8
Hamm, L.L.9
McCullough, P.A.10
Kasiske, B.L.11
Kelepouris, E.12
Klag, M.J.13
Parfrey, P.14
Pfeffer, M.15
Raij, L.16
Spinosa, D.J.17
Wilson, P.W.18
-
2
-
-
33644854296
-
Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences
-
Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 2006; 290: F262-72.
-
(2006)
Am J Physiol Renal Physiol
, vol.290
, pp. F262-F272
-
-
Vaziri, N.D.1
-
3
-
-
0042821576
-
Impact of dyslipidemia in end-stage renal disease
-
Prichard SS. Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 2003; 14: S315-20.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. S315-S320
-
-
Prichard, S.S.1
-
4
-
-
79955794222
-
Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles
-
Vekic J, Zeljkovic A, Bogavac-Stanojevic N, Jelic-Ivanovic Z, Spasojevic Kalimanovska V, Simic-Ogrizovic S, Dopsaj V, Spasic S. Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles. Clin Biochem 2011; 44: 635-41.
-
(2011)
Clin Biochem
, vol.44
, pp. 635-641
-
-
Vekic, J.1
Zeljkovic, A.2
Bogavac-Stanojevic, N.3
Jelic-Ivanovic, Z.4
Spasojevic Kalimanovska, V.5
Simic-Ogrizovic, S.6
Dopsaj, V.7
Spasic, S.8
-
5
-
-
84897112913
-
Association of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patients
-
Vekic J, Zeljkovic A, Jelic-Ivanovic Z, Damjanovic T, Suvakov S, Matic M, Savic-Radojevic A, Simic T, Spasojevic-Kalimanovska V, Gojkovic T, Spasic S, Dimkovic N. Association of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patients. Clin Biochem 2014; 47: 398-403.
-
(2014)
Clin Biochem
, vol.47
, pp. 398-403
-
-
Vekic, J.1
Zeljkovic, A.2
Jelic-Ivanovic, Z.3
Damjanovic, T.4
Suvakov, S.5
Matic, M.6
Savic-Radojevic, A.7
Simic, T.8
Spasojevic-Kalimanovska, V.9
Gojkovic, T.10
Spasic, S.11
Dimkovic, N.12
-
6
-
-
80053935006
-
Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients
-
Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Peco-Antic A, Kostic M, Vasic D, Spasic S. Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients. Transpl Int 2011; 24: 1094-102.
-
(2011)
Transpl Int
, vol.24
, pp. 1094-1102
-
-
Zeljkovic, A.1
Vekic, J.2
Spasojevic-Kalimanovska, V.3
Jelic-Ivanovic, Z.4
Peco-Antic, A.5
Kostic, M.6
Vasic, D.7
Spasic, S.8
-
7
-
-
0345098354
-
A novel and simple method for quantifi cation of small dense LDL
-
Hirano T, Ito Y, Saegusa H, Yoshino G. A novel and simple method for quantifi cation of small dense LDL. J Lipid Res 2003; 44: 2193-201.
-
(2003)
J Lipid Res
, vol.44
, pp. 2193-2201
-
-
Hirano, T.1
Ito, Y.2
Saegusa, H.3
Yoshino, G.4
-
8
-
-
1542343995
-
Clinical signifi cance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method
-
Hirano T, Ito Y, Koba S, Toyoda M, Ikejiri A, Saegusa H, Yamazaki J, Yoshino G. Clinical signifi cance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 2004; 24: 558-63.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 558-563
-
-
Hirano, T.1
Ito, Y.2
Koba, S.3
Toyoda, M.4
Ikejiri, A.5
Saegusa, H.6
Yamazaki, J.7
Yoshino, G.8
-
9
-
-
0036737881
-
Metabolic origin and clinical signifi cance of LDL heterogeneity
-
Berneis KK, Krauss RM. Metabolic origin and clinical signifi cance of LDL heterogeneity. J Lipid Res 2002; 43: 1363-79.
-
(2002)
J Lipid Res
, vol.43
, pp. 1363-1379
-
-
Berneis, K.K.1
Krauss, R.M.2
-
10
-
-
0242288750
-
Low-density lipoprotein size and cardiovascular disease: A reappraisal
-
Sacks FM, Campos H. Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 2003; 88: 4525-32.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 4525-4532
-
-
Sacks, F.M.1
Campos, H.2
-
11
-
-
40749162391
-
Galectin-3 is an amplifi er of infl ammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoat-traction
-
Papaspyridonos M, McNeill E, de Bono JP, Smith A, Burnand KG, Channon KM, Greaves DR. Galectin-3 is an amplifi er of infl ammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoat-traction. Arterioscler Thromb Vasc Biol 2008; 28: 433-40.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 433-440
-
-
Papaspyridonos, M.1
McNeill, E.2
De Bono, J.P.3
Smith, A.4
Burnand, K.G.5
Channon, K.M.6
Greaves, D.R.7
-
12
-
-
0034813639
-
The role of galectin-3 in endocytosis of advanced glycation end products and modifi ed low density lipopro-teins
-
Zhu W, Sano H, Nagai R, Fukuhara K, Miyazaki A, Horiuchi S. The role of galectin-3 in endocytosis of advanced glycation end products and modifi ed low density lipopro-teins. Biochem Biophys Res Commun 2001; 280: 1183-8.
-
(2001)
Biochem Biophys Res Commun
, vol.280
, pp. 1183-1188
-
-
Zhu, W.1
Sano, H.2
Nagai, R.3
Fukuhara, K.4
Miyazaki, A.5
Horiuchi, S.6
-
13
-
-
66349127163
-
Accelerated lipid-induced atherogene-sis in galectin-3-defi cient mice: Role of lipoxidation via receptor-mediated mechanisms
-
Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Cordone S, Taurino M, Serino M, Marano G, Federici M, Pricci F, Pugliese G. Accelerated lipid-induced atherogene-sis in galectin-3-defi cient mice: role of lipoxidation via receptor-mediated mechanisms. Arterioscler Thromb Vasc Biol 2009; 29: 831-6.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 831-836
-
-
Iacobini, C.1
Menini, S.2
Ricci, C.3
Scipioni, A.4
Sansoni, V.5
Cordone, S.6
Taurino, M.7
Serino, M.8
Marano, G.9
Federici, M.10
Pricci, F.11
Pugliese, G.12
-
15
-
-
70450248522
-
Small, dense LDL cholesterol and apolipoprotein B: Relationship with serum lipids and LDL size
-
Vekic J, Zeljkovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Memon L, Spasic S. Small, dense LDL cholesterol and apolipoprotein B: relationship with serum lipids and LDL size. Atherosclerosis 2009; 207: 496-501.
-
(2009)
Atherosclerosis
, vol.207
, pp. 496-501
-
-
Vekic, J.1
Zeljkovic, A.2
Jelic-Ivanovic, Z.3
Spasojevic-Kalimanovska, V.4
Bogavac-Stanojevic, N.5
Memon, L.6
Spasic, S.7
-
16
-
-
0026478022
-
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
-
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfi eld JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
-
(1992)
Lancet
, vol.340
, pp. 1111-1115
-
-
Celermajer, D.S.1
Sorensen, K.E.2
Gooch, V.M.3
Spiegelhalter, D.J.4
Miller, O.I.5
Sullivan, I.D.6
Lloyd, J.K.7
Deanfield, J.E.8
-
17
-
-
1342344698
-
Cellular lipid metabolism and the role of lipids in progressive renal disease
-
Abrass CK. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 2004; 24: 46-53.
-
(2004)
Am J Nephrol
, vol.24
, pp. 46-53
-
-
Abrass, C.K.1
-
19
-
-
33748443205
-
Should we measure routinely the LDL peak particle size?
-
Rizzo M, Berneis K. Should we measure routinely the LDL peak particle size? Int J Cardiol 2006; 107: 166-70.
-
(2006)
Int J Cardiol
, vol.107
, pp. 166-170
-
-
Rizzo, M.1
Berneis, K.2
-
20
-
-
0036413438
-
The malnutrition, infl ammation, and atherosclerosis (MIA) syndrome - The heart of the matter
-
Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, infl ammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol Dial Transplant 2002; 17(Suppl. 11): 28-31.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 28-31
-
-
Pecoits-Filho, R.1
Lindholm, B.2
Stenvinkel, P.3
-
21
-
-
67449122968
-
Lack of association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients
-
Yeo Y, Byun SW, Lee JY, Min WK, Park JS, Kim SB. Lack of association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients. Am J Nephrol 2009; 30: 310-4.
-
(2009)
Am J Nephrol
, vol.30
, pp. 310-314
-
-
Yeo, Y.1
Byun, S.W.2
Lee, J.Y.3
Min, W.K.4
Park, J.S.5
Kim, S.B.6
-
22
-
-
0031898815
-
Galectin-3 expression in human atherosclerotic lesions
-
Nachtigal M, Al-Assaad Z, Mayer EP, Kim K, Monsigny M. Galectin-3 expression in human atherosclerotic lesions. Am J Pathol 1998; 152: 1199-208.
-
(1998)
Am J Pathol
, vol.152
, pp. 1199-1208
-
-
Nachtigal, M.1
Al-Assaad, Z.2
Mayer, E.P.3
Kim, K.4
Monsigny, M.5
-
23
-
-
84877259302
-
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-defi cient mice
-
MacKinnon AC, Liu X, Hadoke PW, Miller MR, Newby DE, Sethi T. Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-defi cient mice. Glycobiology 2013; 23: 654-63.
-
(2013)
Glycobiology
, vol.23
, pp. 654-663
-
-
MacKinnon, A.C.1
Liu, X.2
Hadoke, P.W.3
Miller, M.R.4
Newby, D.E.5
Sethi, T.6
-
24
-
-
84862578799
-
Galectins testing: New promises for the diagnosis and risk stratifi cation of chronic diseases?
-
Gruson D, Ko G. Galectins testing: new promises for the diagnosis and risk stratifi cation of chronic diseases? Clin Biochem 2012; 45: 719-26.
-
(2012)
Clin Biochem
, vol.45
, pp. 719-726
-
-
Gruson, D.1
Ko, G.2
-
25
-
-
67650046377
-
Advanced lipoxidation end-products mediate lipid-induced glomerular injury: Role of receptor-mediated mechanisms
-
Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Mazzitelli G, Cordone S, Pesce C, Pugliese F, Pricci F, Pugliese G. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. J Pathol 2009; 218: 360-9.
-
(2009)
J Pathol
, vol.218
, pp. 360-369
-
-
Iacobini, C.1
Menini, S.2
Ricci, C.3
Scipioni, A.4
Sansoni, V.5
Mazzitelli, G.6
Cordone, S.7
Pesce, C.8
Pugliese, F.9
Pricci, F.10
Pugliese, G.11
-
26
-
-
0037683735
-
Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modifi ed lipoproteins
-
Kim K, Mayer EP, Nachtigal M. Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modifi ed lipoproteins. Biochim Biophys Acta 2003; 1641: 13-23.
-
(2003)
Biochim Biophys Acta
, vol.1641
, pp. 13-23
-
-
Kim, K.1
Mayer, E.P.2
Nachtigal, M.3
|